http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070936-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93319b2e0e6950100f767925da78f8de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d092bead7192f378e856b5e8aa03b246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f68ccf318047296847539756b5101c35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2effa7afdc95cf341ad587762458727d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e654360a557bff83a67ccabfd33f614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_277e2f81c76a83eff7d6f87b886b01f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f0705830bc31429b9b55df8cbec9b3e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2004-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7df27eff4bceb127888777cae510e72a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08af82fc6af16454f93f495f529d4877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca1c8931bac1ca4866464a12a0e9e639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a7a889394257918d67591783faa39ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5235f20f239b95f9ebf18308601b5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cacceca7c7232c12753d60200ab28fe0
publicationDate 2005-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005070936-A1
titleOfInvention 20-esterized camptothecin derivatives, their preparation and the pharmaceutical compositions and the use
abstract The invention is related to new 20-esterized camptothecin derivatives having formula (I), their preparation and the pharmaceutical compositions containing the same. The compounds of formula (I) are used as drug, particularly as antineoplastic drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603759-A
priorityDate 2004-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0109139-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01249777-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397589

Total number of triples: 31.